Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Early Phase 1
1(25.0%)
4Total
N/A(3)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07243405Not ApplicableRecruiting

Neurostimulation for Sleep Disordered Breathing (SDB)

Role: lead

NCT05350332Not ApplicableRecruiting

Effects of Lung Volume on Upper Airway Patency During Drug Induced Sleep Endoscopy

Role: collaborator

NCT06762873Early Phase 1Recruiting

Assessment of OSA in Latin American and Response to Neuromod Therapy

Role: lead

NCT06883617Not ApplicableRecruiting

Neurostimulation for Sleep Disordered Breathing

Role: lead

All 4 trials loaded